The role of inducible nitric oxide synthase for interstitial remodeling of alveolar septa in surfactant protein D-deficient mice.

Surfactant protein D (SP-D) modulates the lung's immune system. Its absence leads to NOS2-independent alveolar lipoproteinosis and NOS2-dependent chronic inflammation, which is critical for early emphysematous remodeling. With aging, SP-D knockout mice develop an additional interstitial fibrotic component. We hypothesize that this age-related interstitial septal wall remodeling is mediated by NOS2. Using invasive pulmonary function testing such as the forced oscillation technique and quasistatic pressure-volume perturbation and design-based stereology, we compared 29-wk-old SP-D knockout (Sftpd(-/-)) mice, SP-D/NOS2 double-knockout (DiNOS) mice, and wild-type mice (WT). Structural changes, including alveolar epithelial surface area, distribution of septal wall thickness, and volumes of septal wall components (alveolar epithelium, interstitial tissue, and endothelium) were quantified. Twenty-nine-week-old Sftpd(-/-) mice had preserved lung mechanics at the organ level, whereas elastance was increased in DiNOS. Airspace enlargement and loss of surface area of alveolar epithelium coexist with increased septal wall thickness in Sftpd(-/-) mice. These changes were reduced in DiNOS, and compared with Sftpd(-/-) mice a decrease in volumes of interstitial tissue and alveolar epithelium was found. To understand the effects of lung pathology on measured lung mechanics, structural data were used to inform a computational model, simulating lung mechanics as a function of airspace derecruitment, septal wall destruction (loss of surface area), and septal wall thickening. In conclusion, NOS2 mediates remodeling of septal walls, resulting in deposition of interstitial tissue in Sftpd(-/-). Forward modeling linking structure and lung mechanics describes the complex mechanical properties by parenchymatous destruction (emphysema), interstitial remodeling (septal wall thickening), and altered recruitability of acinar airspaces.

[1]  M. Selman,et al.  TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? , 2000, American journal of physiology. Lung cellular and molecular physiology.

[2]  J. Cooke,et al.  The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis , 2013, The Journal of pathology.

[3]  Debra L Laskin,et al.  Age-related increases in ozone-induced injury and altered pulmonary mechanics in mice with progressive lung inflammation. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[4]  A. Gow,et al.  Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice. , 2004, The Journal of infectious diseases.

[5]  J. Bates,et al.  Modeling the dynamics of recruitment and derecruitment in mice with acute lung injury. , 2008, Journal of applied physiology.

[6]  M Ikegami,et al.  Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Whitsett,et al.  Surfactant Protein D Regulates NF-κB and Matrix Metalloproteinase Production in Alveolar Macrophages via Oxidant-Sensitive Pathways1 , 2001, The Journal of Immunology.

[8]  M. Ochs,et al.  Quantitative microscopy of the lung: a problem-based approach. Part 2: stereological parameters and study designs in various diseases of the respiratory tract. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[9]  C. Epstein,et al.  Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Hyde,et al.  Abrogation of bleomycin-induced lung fibrosis by nitric oxide synthase inhibitor, aminoguanidine in mice. , 2002, Nitric oxide : biology and chemistry.

[11]  S. Simon,et al.  Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations , 2013, European Respiratory Journal.

[12]  P. Brillet,et al.  Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity , 2005, European Respiratory Journal.

[13]  J. Nick,et al.  By Binding SIRPα or Calreticulin/CD91, Lung Collectins Act as Dual Function Surveillance Molecules to Suppress or Enhance Inflammation , 2003, Cell.

[14]  S. Rounds,et al.  Combined pulmonary fibrosis and emphysema syndrome: a review. , 2012, Chest.

[15]  Feng Wang,et al.  Characteristics of pulmonary inflammation in combined pulmonary fibrosis and emphysema. , 2012, Chinese Medical Journal.

[16]  Andrew J Gow,et al.  Surfactant protein-D, a mediator of innate lung immunity, alters the products of nitric oxide metabolism. , 2004, American journal of respiratory cell and molecular biology.

[17]  S. Tschanz,et al.  Design-based stereology: Planning, volumetry and sampling are crucial steps for a successful study. , 2014, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[18]  A. Gow,et al.  Selective Inhibition of Inducible NO Synthase Activity In Vivo Reverses Inflammatory Abnormalities in Surfactant Protein D-Deficient Mice1 , 2007, The Journal of Immunology.

[19]  J. Bates,et al.  Tumor Necrosis Factor–α Overexpression in Lung Disease , 2005 .

[20]  A. Gow,et al.  Alveolar surfactant protein D content modulates bleomycin-induced lung injury. , 2005, American journal of respiratory and critical care medicine.

[21]  E. Weibel,et al.  American Thoracic Society Documents An Official Research Policy Statement of the American Thoracic Society/European Respiratory Society: Standards for Quantitative Assessment of Lung Structure , 2010 .

[22]  J. Polak,et al.  iNOS gene upregulation is associated with the early proliferative response of human lung fibroblasts to cytokine stimulation , 2002, The Journal of pathology.

[23]  A. Boulares,et al.  Requirement for Inducible Nitric Oxide Synthase in Chronic Allergen Exposure-Induced Pulmonary Fibrosis but Not Inflammation , 2010, The Journal of Immunology.

[24]  M. Ochs,et al.  A brief update on lung stereology , 2006, Journal of microscopy.

[25]  Robert B. Darling,et al.  Effects of low work function metals on the barrier height of sulfide‐treated n‐type GaAs(100) , 1992 .

[26]  E R Weibel,et al.  A simple tool for stereological assessment of digital images: the STEPanizer , 2011, Journal of microscopy.

[27]  Y. Wang,et al.  Suppression of bleomycin-induced nitric oxide production in mice by taurine and niacin. , 2000, Nitric oxide : biology and chemistry.

[28]  M. Ochs,et al.  Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient mice , 2007, Respiratory research.

[29]  Matthias Ochs,et al.  Quantitative microscopy of the lung: a problem-based approach. Part 1: basic principles of lung stereology. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[30]  Andrew J. Gow,et al.  NOS2 Is Critical to the Development of Emphysema in Sftpd Deficient Mice but Does Not Affect Surfactant Homeostasis , 2014, PloS one.

[31]  A. Gow,et al.  S-Nitrosylation of Surfactant Protein-D Controls Inflammatory Function , 2008, PLoS biology.

[32]  Matthias Ochs,et al.  Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. , 2010, Journal of applied physiology.

[33]  J. Fredberg,et al.  Input impedance and peripheral inhomogeneity of dog lungs. , 1992, Journal of applied physiology.

[34]  E. B. Jensen,et al.  Determination of membrane thickness distribution from orthogonal intercepts , 1979, Journal of microscopy.

[35]  J. Nyengaard,et al.  GM-CSF mediates alveolar epithelial type II cell changes, but not emphysema-like pathology, in SP-D-deficient mice. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[36]  Susan E. Wert,et al.  Surfactant Protein-D Regulates Surfactant Phospholipid Homeostasis in Vivo * , 1998, The Journal of Biological Chemistry.

[37]  W. Scherle,et al.  A simple method for volumetry of organs in quantitative stereology. , 1970, Mikroskopie.

[38]  Peter D Sly,et al.  In Vivo Measurements of Changes in Respiratory Mechanics with Age in Mice Deficient in Surfactant Protein D , 2003, Pediatric Research.

[39]  C. Ruppert,et al.  Translational Research in Acute Lung Injury and Pulmonary Fibrosis Linking progression of fibrotic lung remodeling and ultrastructural alterations of alveolar epithelial type II cells in the amiodarone mouse model , 2015 .

[40]  W. Janssen,et al.  Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. , 2008, American journal of respiratory and critical care medicine.

[41]  J. Bates,et al.  Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. , 2005, American journal of respiratory and critical care medicine.

[42]  Debra L Laskin,et al.  Acute chlorine gas exposure produces transient inflammation and a progressive alteration in surfactant composition with accompanying mechanical dysfunction. , 2014, Toxicology and applied pharmacology.

[43]  H. Gundersen,et al.  Design-based stereological analysis of the lung parenchymal architecture and alveolar type II cells in surfactant protein A and D double deficient mice. , 2005, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[44]  A. Gow,et al.  Prolonged injury and altered lung function after ozone inhalation in mice with chronic lung inflammation. , 2012, American journal of respiratory cell and molecular biology.